.NYU Langone Health has announced that a team of surgeons have performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a woman with heart and kidney failure renalinterventions.net/first-ever-com…

Renal Interventions issue 11 is now live! With featured content from the ASDIN annual meeting, as well as a profile on Gerald Beathard and insights on #renaldenervation , this issue is packed with exciting content! renalinterventions.net/renal-interven…

Beate Lindberb draws this morning’s first Juxtarenal controversies session to a close with a podium first presentation of renal protection in open repair for juxtarenal AAA #CX2024

The international approach to vascular access problems roundtable is generating lots of debate and different options in theatre three #cxsymposium2024

The final presentation of the morning session sees Andrew Holden present five-year data from the IN.PACT AV Access study - he avers that 'we now know which DCB to use' based on improved outcomes + comparable all-cause mortality with IN.PACT vs plain balloon
#CX2024

A stellar panel of #VascularAccess experts from across Europe, USA and South America are currently discussing the need for new technologies in this space at #CX2024
Paul Gibbs Narayan Karunanithy Robert Shahverdyan, MD 🇦🇲🇩🇪 Leonardo Ellen Dillavou Raphaël Coscas Nick Inston

. Raphaël Coscas outlines findings from the investigator-led ABISS trial, which compared the Lutonix DCB to plain balloon angioplasty. Intention-to-treat analysis did not find a major difference between the two, although per-protocol analysis found the former was superior
#CX2024

This debate reveals that endoAVFs remain a divisive topic, as the #CX2024 audience is split almost 50/50 over whether these technologies are a 'failed experiment'. Nick Inston feels this is a 'fascinating' result and predicts the debate will rage on for years to come

Koen van der Bogt presents the work being done in The Netherlands to develop a 'dynamic AVF' that can effectively be turned on and off at intervals. Despite remaining challenge of non-maturation, Nick Inston describes this as a 'really innovative and futuristic' concept
#CX2024

.David Kingsmore asserts that grafts are better than fistulas, as they reduce the need for catheters and futile surgeries, and produce comparable outcomes including equivalent patency - Robert Shahverdyan, MD 🇦🇲🇩🇪 disputes this on several counts
#CX2024

.David Kingsmore notes that a major drawback to many vascular access registries is the fact that they include 'what was done, but not what wasn't done', highlighting a problem created by selection biases
#CX2024

Kicking off the #VascularAccess programme at #CX2024 , Robert Shahverdyan, MD 🇦🇲🇩🇪 updates delegates on the Hamburg registry - importance of ultrasound experience, pre, peri and postoperatively, is among key messages. He also extolls virtues of axillary blocks and stent grafts